Allspring Global Investments
DNLI icon

Allspring Global Investments’s Denali Therapeutics DNLI Stock Holding History

Allspring Global Investments’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,676
Closed -$165K – 1947
2024
Q3 		$165K Sell
5,676
-421
-7% -$10.4K ﹤0.01% 1711
2024
Q2 		$142K Sell
6,097
-63
-1% -$1.21K ﹤0.01% 1786
2024
Q1 		$126K Buy
6,160
+519
+9% +$9.75K ﹤0.01% 1799
2023
Q4 		$121K Buy
5,641
+475
+9% +$9.41K ﹤0.01% 1774
2023
Q3 		$107K Sell
5,166
-327
-6% -$8.29K ﹤0.01% 1975
2023
Q2 		$162K Sell
5,493
-115
-2% -$3.23K ﹤0.01% 1877
2023
Q1 		$129K Buy
5,608
+2,366
+73% +$65.1K ﹤0.01% 1952
2022
Q4 		$90.2K Sell
3,242
-71
-2% -$2.11K ﹤0.01% 2113
2022
Q3 		$101K Buy
3,313
+1,005
+44% +$32.7K ﹤0.01% 2083
2022
Q2 		$67K Sell
2,308
-37,909
-94% -$993K ﹤0.01% 2169
2022
Q1 		$1.29M Buy
40,217
+1,605
+4% +$55.2K ﹤0.01% 1737
2021
Q4 		$1.72M Buy
+38,612
New +$1.83M ﹤0.01% 1621

Other funds holding DNLI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Allspring Global Investments's DNLI Position: Q4 2024 in Review

Allspring Global Investments sold out of Denali Therapeutics (DNLI) in Q4 2024, closing a stake of 5,676 shares — an estimated $165K sold.

Allspring Global Investments first reported a position in DNLI in Q4 2021 and held it in 12 quarters. The position peaked at $1.72M in Q4 2021. 223 funds tracked by Wall St. Rank hold DNLI as of Q4 2024.

  • Allspring Global Investments reported no remaining Denali Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Allspring Global Investments sold 5,676 Denali Therapeutics shares in Q4 2024, an estimated $165K.
  • Allspring Global Investments first reported a position in Denali Therapeutics in Q4 2021 and held it in 12 quarters.
  • Allspring Global Investments's Denali Therapeutics position peaked at $1.72M in Q4 2021.
  • 223 funds tracked by Wall St. Rank held Denali Therapeutics as of Q4 2024.

Based on Allspring Global Investments's 13F filing for Q4 2024, filed 29 Jan 2025.